Senior Software Engineer(Python Cloud AI Engineer)) at Bristol-Myers Squibb

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Expertise in Python programming
Experience with cloud platforms (AWS, Azure, GCP)
Knowledge of cloud native solutions, microservices, APIs, and serverless applications
Proficiency in building and optimizing data pipelines, ETL processes, and machine learning models
Skills in ensuring security, reliability, and performance of cloud infrastructure and applications (best practices, monitoring, automated testing)
Ability to participate in code reviews, architecture discussions, and agile processes
Capability to troubleshoot cloud infrastructure, applications, and data pipelines
Continuous learning of latest cloud technologies, trends, and best practices
Experience providing technical guidance and mentorship to junior developers
Strong documentation and communication skills for technical and non-technical stakeholders

Responsibilities

Partner with cloud developers, data engineers, AI/ML specialists, and data scientists to design, develop, and implement cloud native solutions
Collaborate with data engineers and data scientists to build and optimize data pipelines, ETL processes, and machine learning models in the cloud
Develop and maintain microservices, APIs, and serverless applications
Ensure the security, reliability, and performance of cloud infrastructure and applications by implementing best practices, monitoring tools, and automated testing
Participate in code reviews, architecture discussions, and agile development processes to ensure high-quality, maintainable, and scalable code
Troubleshoot and resolve issues related to cloud infrastructure, applications, and data pipelines
Continuously research and stay up-to-date with the latest cloud technologies, trends, and best practices to drive innovation and improve existing solutions
Provide technical guidance and mentorship to junior developers and team members
Document and communicate technical designs, processes, and solutions to both technical and non-technical stakeholders

Skills

Python

AWS

Azure

GCP

ETL

Data Pipelines

Microservices

APIs

Serverless

Machine Learning

Cloud Native

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free